Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by JingLei Hu
Identification of Gene Modules Associated With Survival of Diffuse Large B-Cell Lymphoma Treated With CHOP-based Chemotherapy
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Related publications
Progressive Diffuse Large B-Cell Lymphoma With TP53 Gene Mutation Treated With Chidamide-Based Chemotherapy
Immunotherapy
Oncology
Allergy
Immunology
Diffuse Large B-Cell Lymphoma Presenting With Gastrocolic Fistula and Successfully Treated With R-Chop Chemotherapy
Tenri Medical Bulletin
Multiplex Polymerase Chain Reaction-Based Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Treated With R-Chop
British Journal of Haematology
Hematology
Tumor Necrosis as a Prognostic Factor of Diffuse Large B-Cell Lymphoma Treated With R-Chop Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
MELK Serves as a Potent Independent Biomarker to Predict Survival of Diffuse Large B-Cell Lymphoma Patients Treated With Rituximab-Chop Regimen
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Response of Diffuse Large B-Cell Lymphoma Treated With R-Chop and Prognostic Factors Associated: A Single Institution Analysis in Lima, Peru
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Significance of Ki67 and Its Correlation With Mitotic Index in Dogs With Diffuse Large B-Cell Lymphoma Treated With 19-Week CHOP-based Protocol
Journal of Veterinary Diagnostic Investigation
Veterinary
Gene Mutations and Copy Number Alterations (Cna) Predict for Early Failure in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Treated With R-Chop
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Blood Lymphocyte-To-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated With R-Chop
PLoS ONE
Multidisciplinary
